# OMLYCLO

NDC: 72606-036
Generic name: omalizumab-igec
Labeler / Manufacturer: CELLTRION USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20261005

FDA application: BLA761399

## Active ingredients

- OMALIZUMAB: 150 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72606-036"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72606-036